Log in

OTCMKTS:ASNBAdvanSource Biomaterials Corpration Stock Price, Forecast & News

$0.03
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.02
MA: $0.03
$0.04
52-Week Range
$0.02
Now: $0.03
$0.23
Volume5,110 shs
Average Volume63,539 shs
Market Capitalization$713,468.00
P/E Ratio3.32
Dividend YieldN/A
Beta-0.54
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.75 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ASNB
CUSIPN/A
Phone424-256-8560

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.35 million
Cash Flow$0.02 per share
Book Value($0.01) per share

Profitability

Net Income$330,000.00

Miscellaneous

Employees11
Market Cap$713,468.00
Next Earnings Date10/5/2020 (Estimated)
OptionableNot Optionable

Receive ASNB News and Ratings via Email

Sign-up to receive the latest news and ratings for ASNB and its competitors with MarketBeat's FREE daily newsletter.

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) Frequently Asked Questions

How has AdvanSource Biomaterials Corpration's stock been impacted by COVID-19 (Coronavirus)?

AdvanSource Biomaterials Corpration's stock was trading at $0.1470 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ASNB shares have decreased by 77.4% and is now trading at $0.0332. View which stocks have been most impacted by Coronavirus.

When is AdvanSource Biomaterials Corpration's next earnings date?

AdvanSource Biomaterials Corpration is scheduled to release its next quarterly earnings announcement on Monday, October 5th 2020. View our earnings forecast for AdvanSource Biomaterials Corpration.

How were AdvanSource Biomaterials Corpration's earnings last quarter?

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) released its quarterly earnings results on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.02. During the same period in the prior year, the business posted $0.27 EPS. View AdvanSource Biomaterials Corpration's earnings history.

Has AdvanSource Biomaterials Corpration been receiving favorable news coverage?

News headlines about ASNB stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. AdvanSource Biomaterials Corpration earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about AdvanSource Biomaterials Corpration.

Who are some of AdvanSource Biomaterials Corpration's key competitors?

What other stocks do shareholders of AdvanSource Biomaterials Corpration own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AdvanSource Biomaterials Corpration investors own include Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Diagnostics Group (IDXG), Sphere 3D (ANY), Champions Oncology (CSBR), CannTrust (CTST), Curaleaf (CURLF) and ITT Educational Services (ESINQ).

Who are AdvanSource Biomaterials Corpration's key executives?

AdvanSource Biomaterials Corpration's management team includes the following people:
  • Michael F. Adams, President & Chief Executive Officer
  • Khristine L. Carroll, Senior Vice President-Commercial Operations

What is AdvanSource Biomaterials Corpration's stock symbol?

AdvanSource Biomaterials Corpration trades on the OTCMKTS under the ticker symbol "ASNB."

How do I buy shares of AdvanSource Biomaterials Corpration?

Shares of ASNB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AdvanSource Biomaterials Corpration's stock price today?

One share of ASNB stock can currently be purchased for approximately $0.03.

How big of a company is AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration has a market capitalization of $713,468.00 and generates $3.35 million in revenue each year. AdvanSource Biomaterials Corpration employs 11 workers across the globe.

What is AdvanSource Biomaterials Corpration's official website?

The official website for AdvanSource Biomaterials Corpration is www.advbiomaterials.com.

How can I contact AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration's mailing address is 229 ANDOVER STREET, WILMINGTON MA, 01887. The company can be reached via phone at 424-256-8560 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.